Spitzoid melanoma of the finger: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 03 06 2024
accepted: 09 08 2024
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

Melanoma is the most malignant skin tumor, with a high metastatic potential. Spitzoid melanoma is a subtype of melanoma requiring rapid management and extensive tumor resection. We have set the goal to recognize anatomical peculiarities and difficulties diagnoses posed by this type of tumor, as well as to recognize the management modalities, especially the surgical one, of malignant spitzoid melanoma. A 25-year-old Tunisian male patient had consulted for nodular lesion of the right index, evolving for 4 years. A malignant tumor was strongly suspected, then confirmed as a melanoma by a biopsy excision. Initially, the excision was incomplete in depth, suggesting a complementary surgery, but the patient refused it; 3 years later, the patient again consulted after the appearance of an axillary lymphadenopathy and worsening of the skin lesion. A supplement of tumor removal with lymph node biopsy were performed. It was decided to perform an amputation of the second ray and the first commissure with cheiroplasty, reconstructing a four-finger hand. An homolateral axillary cleaning was performed at the same time. The postoperative result is considered esthetically and functionally satisfying. The evolution was marked by the appearance of pulmonary metastases, requiring adjuvant chemotherapy. A regression of the nodule under the mammary skin and total disappearance of axillary nodes have been marked; but the patient's condition rapidly deteriorated, and he died after a 2-month decline. Spitzoid melanoma is exceptional, posing difficulties in diagnostics, and it should not be underestimated, considering that it may involve the vital prognosis. Knowledge of this rare form of melanoma is important to avoid misdiagnosis, which delays diagnosis and subsequent therapy.

Sections du résumé

BACKGROUND BACKGROUND
Melanoma is the most malignant skin tumor, with a high metastatic potential. Spitzoid melanoma is a subtype of melanoma requiring rapid management and extensive tumor resection. We have set the goal to recognize anatomical peculiarities and difficulties diagnoses posed by this type of tumor, as well as to recognize the management modalities, especially the surgical one, of malignant spitzoid melanoma.
CASE PRESENTATION METHODS
A 25-year-old Tunisian male patient had consulted for nodular lesion of the right index, evolving for 4 years. A malignant tumor was strongly suspected, then confirmed as a melanoma by a biopsy excision. Initially, the excision was incomplete in depth, suggesting a complementary surgery, but the patient refused it; 3 years later, the patient again consulted after the appearance of an axillary lymphadenopathy and worsening of the skin lesion. A supplement of tumor removal with lymph node biopsy were performed. It was decided to perform an amputation of the second ray and the first commissure with cheiroplasty, reconstructing a four-finger hand. An homolateral axillary cleaning was performed at the same time. The postoperative result is considered esthetically and functionally satisfying. The evolution was marked by the appearance of pulmonary metastases, requiring adjuvant chemotherapy. A regression of the nodule under the mammary skin and total disappearance of axillary nodes have been marked; but the patient's condition rapidly deteriorated, and he died after a 2-month decline.
CONCLUSION CONCLUSIONS
Spitzoid melanoma is exceptional, posing difficulties in diagnostics, and it should not be underestimated, considering that it may involve the vital prognosis. Knowledge of this rare form of melanoma is important to avoid misdiagnosis, which delays diagnosis and subsequent therapy.

Identifiants

pubmed: 39237979
doi: 10.1186/s13256-024-04752-4
pii: 10.1186/s13256-024-04752-4
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413

Informations de copyright

© 2024. The Author(s).

Références

Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325(3):171–82.
doi: 10.1056/NEJM199107183250306 pubmed: 1805813
Warso M, Gray T, Gonzalez M. Melanoma of the hand. J Hand Surg. 1997;2:354–60.
doi: 10.1016/S0363-5023(97)80178-5
Kamino H. Spitzoid melanoma. Clin Dermatol. 2009;27(6):545–55.
doi: 10.1016/j.clindermatol.2008.09.013 pubmed: 19880042
Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591–609.
pubmed: 18859360 pmcid: 1942798
Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnostic et pronostic. Cancer. 1953;6(1):1–45.
doi: 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C pubmed: 13009650
Barnhill RL. The Spitzoid lesion : rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessmen. Modern Pathol. 2006;19(2):S21-33.
doi: 10.1038/modpathol.3800519
Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC, et al. Atypical Spitz naevus/tumeurs : absence de consensus pour le diagnostic, discrimination par mélanome, et prédiction des résultats. Hum Pathol. 1999;30(5):513–20.
doi: 10.1016/S0046-8177(99)90193-4 pubmed: 10333219
Keyhani A. Comparaison du comportement clinique du mélanome des mains et des pieds. Une étude Cancer. 1977;40(6):3168–73.
Kato T, Suetake T, Sugiyama Y, Tanita Y, Kumasaka K, Takematsu H, et al. Improvement taux de survie des patients atteints d’un mélanome acral observé au cours des 22 dernières années à Sendai. Japon Clin Exp Dermatol. 1993;18(2):107–10.
doi: 10.1111/j.1365-2230.1993.tb00988.x
Sagebiel RW, Banda PW, Schneider JS, Crutcher WA. Age distribution and histologic patterns of dysplastic nevi. J Am Acad Dermatol. 1985;13(6):975–82.
doi: 10.1016/S0190-9622(85)70248-4 pubmed: 4078104
Goh EH, Zarina AL, Thambidorai CR, Maizaton AA, Siti AMA, Somasundram S. Amelanotic spitzoid melanoma in a prepubescent boy. Pediatr Surg Int. 2008;4:447–9.
doi: 10.1007/s00383-007-1923-9
Fabrizi G, Massi G. Spitzoid malignant melanoma in teenagers : an entity with no better pronostic supérieur à celui d’autres formes de mélanome. Histopathology. 2001;38(5):448–53.
doi: 10.1046/j.1365-2559.2001.01102.x pubmed: 11422482
Quinn MJ, Thompson JE, Crotty K, McCarthy WH, Coates AS. Subungual melanoma of. J Hand Surg. 1996;21(3):506–5011.
doi: 10.1016/S0363-5023(96)80371-6
Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113(6):1065–9.
doi: 10.1046/j.1523-1747.1999.00787.x pubmed: 10594753
Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.
doi: 10.1016/S0002-9440(10)64609-3 pubmed: 10980135 pmcid: 1885704
Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, et al. Risk assessment for néoplasmes mélanocytaires atypiques spitzoïdes utilisant FISH pour identifier la copie chromosomique. Am J Surg Pathol. 2013;37(5):676–84.
doi: 10.1097/PAS.0b013e3182753de6 pubmed: 23388126
Bergman R, Malkin L, Sabo E, Kerner H. MIB-1, anticorps monoclonal, pour déterminer activité proliférative de l’antigène Ki-67 en complément du différentiel histopathologique diagnostic de Spitz nevi. J Am Acad Dermatol. 2001;44(3):500–4.
doi: 10.1067/mjd.2001.111635 pubmed: 11209122
Kopf AW, Gross DF, Rogers GS, Rigel DS, Hellman LJ, Levenstein M, et al. Prognostic index for malignant melanoma. Cancer. 1987;59(6):1236–41.
doi: 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I pubmed: 3815299
Wanebo HJ, Fortner JG, Woodruff J, MacLean B, Binkowski E. Selection of the optimum traitement chirurgical du mélanome de stade I par profondeur de microinvasion : utilisation de la Clark-Breslow. Ann Surg. 1975;182(3):302–15.
doi: 10.1097/00000658-197509000-00013 pubmed: 1164058 pmcid: 1343944
Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma mise en scène: changements fondés sur des données probantes au sein du comité mixte américain sur le cancerCA Cancer. J Clin. 2017;67(6):472–92.
Hove LM, Akslen LA. Clinicopathological characteristics of melanomas of the hand. J Hand Surg. 1999;24(4):460–4.
doi: 10.1054/JHSB.1999.0155
Boukredera M, Benhabiles A. Mélanome malin unguéal du pouce traité par exérèse et interférant alpha—survie à 10 ans à propos d’un cas. Hand Surg Rehabil. 2017;36(6):471–2.
doi: 10.1016/j.hansur.2017.10.133
LeBoit PE. What do these cells prove? Am J Dermatopathol. 2003;25(4):355–6.
doi: 10.1097/00000372-200308000-00015 pubmed: 12876498
Ferrara G, Errico ME, Donofrio V, Zalaudek I, Argenziano G. Melanocytic tumors of potentiel malin incertain dans l’enfance : avons-nous vraiment besoin
.
Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K, et al. Efficacy of surgical margins of 2 cm for melanoma of average thickness (1 to 4 mm) results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218(3):262–9.
doi: 10.1097/00000658-199309000-00005 pubmed: 8373269 pmcid: 1242959
Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma. comparison of excision with margins of 1 or 3 cm N. Engl J Med. 1988;318(18):1159–62.
doi: 10.1056/NEJM198805053181804
Schonauer F, Schaden D, Teo TC. excision. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 1999;25(4):424–6.
Küntscher MV, Erdmann D, Homann HH, Steinau HU, Levin SL, Germann G. The concept Net flaps: classification, indications and analysis of their clinical value. Plast Reconstr Surg. 2001;108(4):885–96.
doi: 10.1097/00006534-200109150-00011 pubmed: 11547143
Littler JW. Architectural principles of reconstructive hand surgery. Plast Reconstr Surg. 1951;8(4):331.
doi: 10.1097/00006534-195110000-00025
De Cheveigné C, Croutzet P, Ferreira B, Gaston-Nouvel A. door» by association of a cheiroplasty and a posterior interosseous flap, to comments on 3 cases. Chir Main. 2014;33(6):416.

Auteurs

Mohamed Ali Rekik (MA)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia.
University of Medicine of Sfax, Sfax, Tunisia.

Amal Rouabeh (A)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia.
University of Medicine of Sfax, Sfax, Tunisia.

Yahya Guermazi (Y)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia. Yahya.Guermazi20@gmail.com.
University of Medicine of Sfax, Sfax, Tunisia. Yahya.Guermazi20@gmail.com.

Fedi Dahech (F)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia.
University of Medicine of Sfax, Sfax, Tunisia.

Zoubeir Ellouz (Z)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia.
University of Medicine of Sfax, Sfax, Tunisia.

Hassib Keskes (H)

Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia.
University of Medicine of Sfax, Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH